In addition, ZFX expression correlated with tumor differentiation (p = 0.005) and TNM stage (p = 0.003), while no correlation was observed with other clinical parameters, including gender (p = 1.000), age (p = 0.900), tumor location (p = 0.706) and tumor size (p = 0.799) (Table 1). This evidence concerns the gene ZFX and neoplasm.